rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Bliss GVS Pharma Ltd.

506197 BLISSGVS Group (B)

22 Jul,15:29
108.30
-1.85 (-1.68%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Bliss GVS Pharma Ltd.

BUYSELL
19,560 110.15 113.05 - 108.20 148.95 - 77.65 1,137.15
NSE | BSE

Bliss GVS Pharma Ltd.

BLISSGVS

22 Jul,15:40
108.98
-1.30 (-1.18%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Bliss GVS Pharma Ltd.

BUYSELL
310,244 110.28 114.00 - 108.10 149.60 - 77.35 34,164,069.28
(Rs. Crore)

Financial Results of Bliss GVS Pharma Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales605.46598.34636.36465.51441.95
Operating profit107.1790.16109.2091.46100.17
Interest5.8110.064.324.194.56
Gross profit134.86130.87137.50104.95130.54
EPS (Rs)4.848.218.946.548.95

See more in Research Center »

Statements:Balance Sheet  |  P&L  |  Cash Flow
More:Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

About Bliss GVS Pharma Ltd.

Bliss GVS Pharma Limited is an Indian pharmaceutical company headquartered in Mumbai, India. Bliss GVS primarily develops, manufactures and markets products across various therapeutic categories including Anti-fungal, Contraceptive, Laxative, Anti-haemorrhoidal, Anti-spasmodic, Anti-malarial, Anti-biotic, Anti-microbial, Anti-inflammatory, Antipyretic, Analgesic and several others. Wikipedia

News for Pharmaceuticals and health care

CapitaLand India...
CapitaLand India Trust Acquires Rs 676 Cr Office Building in Navi Mumbai
CapitaLand India Trust (CLINT) has completed the acquisition of a 0.82 million sq ft office building in Navi Mumbai for Rs 676 crore. The building is fully leased to reputed Indian and...
Jul 22, 2024 18:34
Retail Investors'...
Retail Investors' Derivatives Trading Driven by 'Gambling Instincts': Eco Survey
Economic Survey 2023-24 highlights the rise of retail investor participation in derivatives trading, linking it to 'gambling instincts' and warning of potential risks. The survey emphasizes the...
Jul 22, 2024 18:30
Pvt Sector's...
Pvt Sector's Toxic Habits Impact India's Economy: Eco Survey
India's Economic Survey highlights the private sector's role in unhealthy habits impacting public health and productivity, urging businesses to prioritize employee well-being and sustainable...
Jul 22, 2024 18:24
RBI Warns of...
RBI Warns of Risks From Single Vendor Reliance
RBI Deputy Governor flags risks of relying on single vendors for services, citing Microsoft outage. He also warns about lack of customer redressal mechanisms among lending service providers.
Jul 22, 2024 18:13
India Economic...
India Economic Survey 2023-24: Conservative Growth Forecast at 6.5-7%
India's Economic Survey projects a conservative growth of 6.5-7% for 2024-25, citing global uncertainties and domestic challenges. Experts weigh in on the forecast and its implications.
Jul 22, 2024 18:03

More News »

Top News

CapitaLand India...
CapitaLand India Trust Acquires Rs 676 Cr Office Building in Navi Mumbai
CapitaLand India Trust (CLINT) has completed the acquisition of a 0.82 million sq ft office building in Navi Mumbai for Rs 676 crore. The building is fully leased to reputed Indian and...
Jul 22, 2024 18:34
Retail Investors'...
Retail Investors' Derivatives Trading Driven by 'Gambling Instincts': Eco Survey
Economic Survey 2023-24 highlights the rise of retail investor participation in derivatives trading, linking it to 'gambling instincts' and warning of potential risks. The survey emphasizes the...
Jul 22, 2024 18:30
Arunachal to...
Arunachal to Terminate Power Project Agreements: Deputy CM
Arunachal Pradesh government is considering terminating agreements with power developers who haven't fulfilled their commitments, with 53 MoAs already terminated. The state has a massive hydropower...
Jul 22, 2024 18:28
Pvt Sector's...
Pvt Sector's Toxic Habits Impact India's Economy: Eco Survey
India's Economic Survey highlights the private sector's role in unhealthy habits impacting public health and productivity, urging businesses to prioritize employee well-being and sustainable...
Jul 22, 2024 18:24
RBI Warns of...
RBI Warns of Risks From Single Vendor Reliance
RBI Deputy Governor flags risks of relying on single vendors for services, citing Microsoft outage. He also warns about lack of customer redressal mechanisms among lending service providers.
Jul 22, 2024 18:13

More Top News »

Report Card

PE Ratios
22.77
EPS (Rs.)
4.84
Sales (Rs. Cr)
163.82
Face Value (Rs.)
1
Net Profit Margin (%)
8.36
Last Bonus
3:5
Last Dividend(%)
50
Return on Average Equity
5.12

BSE Announcements from Bliss GVS Pharma Ltd. (See all)

announcement Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate - 4 day(s) ago
announcement Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2024 - 5 day(s) ago

Compare 'Bliss GVS Pharma Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,593.65
  • Compare
  • Divi's Laboratories Ltd.
  • 4,582.30
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,185.30
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,665.10
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,053.90
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,517.15
  • Compare
  • Max Healthcare Institute Ltd.
  • 933.40
  • Compare
  • Alkem Laboratories Ltd.
  • 5,265.25
  • Compare

Mutual Funds Invested

REDIFFGURUS

My husband is 50 and I am 47. We have a combined...

i have a monthly budget of 5000 to invest in mutual...

I was running a bussiness from last seven year with...

Ill be 26yrs old in October. My monthly salary is...

i am a retired PSU employee and in FY 2324, have...

Hello Sir, I plan to invest in the following funds...

More REDIFFGURUS

RediffGurus

Money question

Hi, I am employed in Maldives from last one year and...

Bliss GVS Pharma Ltd. performance snapshot

If you had invested Rs.  in Bliss GVS Pharma Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio
Bliss GVS Pharma Ltd.
Share Price » Fundamentals » Financial » Technicals » Trade Now »

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume

ALL MONEYWIZ PAGES

rediff on the net© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
Close
Add Bliss GVS Pharma Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Bliss GVS Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close